SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001424884-13-000038
Filing Date
2013-08-19
Accepted
2013-08-19 16:43:01
Documents
9
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 963359
2 exhibit31-1.htm EX-31.1 13811
3 exhibit32-1.htm EX-32.1 5858
  Complete submission text file 0001424884-13-000038.txt   3322337

Data Files

Seq Description Document Type Size
4 tpiv-20130331.xml EX-101.INS 323462
5 tpiv-20130331.xsd EX-101.SCH 17385
6 tpiv-20130331_cal.xml EX-101.CAL 12145
7 tpiv-20130331_def.xml EX-101.DEF 8497
8 tpiv-20130331_lab.xml EX-101.LAB 86313
9 tpiv-20130331_pre.xml EX-101.PRE 62794
Mailing Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6
Business Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6 604-264-8274
TAPIMMUNE INC (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27239 | Film No.: 131048694
SIC: 2834 Pharmaceutical Preparations